CD44 is closely related to tumor resistance, and the CD44+/CD24− phenotype may be an important factor of malignant relapse with chemoresistance in patients with surgically resected invasive ductal carcinoma [28]. Here, CD44 is linked to invasive ductal breast carcinoma.